{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:04:19Z","timestamp":1788519859254,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ghpjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.genhosppsych.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,10,13]],"date-time":"2014-10-13T19:09:09Z","timestamp":1413227349000},"page":"97.e11-97.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ziconotide-induced psychosis: a case report"],"prefix":"10.1016","volume":"37","author":[{"given":"Stephanie V.","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Waldfogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(10)60354-6","article-title":"Ziconotide for the treatment of severe chronic pain","volume":"375","author":"Schmidtko","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0010","series-title":"Prialt [prescribing information]","author":"Prialt (ziconotide)","year":"2013"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpainsymman.2005.10.003","article-title":"A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain","volume":"31","author":"Rauck","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS","volume":"291","author":"Staats","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0091270003253349","article-title":"Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients","volume":"43","author":"Wermeling","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40263-013-0107-5","article-title":"Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics","volume":"27","author":"Sanford","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0040","first-page":"147","article-title":"Treatment challenges and complications with ziconotide monotherapy in established pump patients","volume":"9","author":"Thompson","year":"2006","journal-title":"Pain Physician"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.genhosppsych.2014.10.001_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/appi.psy.43.1.63","article-title":"Intractable delirium associated with ziconotide successfully treated with electroconvulsive therapy","volume":"43","author":"Levin","year":"2002","journal-title":"Psychosomatics"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314002631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314002631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T15:25:38Z","timestamp":1538148338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834314002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0163834314002631"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.10.001","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ziconotide-induced psychosis: a case report","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}